Health Catalyst Inc (NASDAQ: HCAT) Surprised Bears With Its Forecast.

In the last trading session, 1.39 million shares of the Health Catalyst Inc (NASDAQ:HCAT) were traded, and its beta was 1.48. Most recently the company’s share price was $4.52, and it changed around -$0.08 or -1.74% from the last close, which brings the market valuation of the company to $317.35M. HCAT currently trades at a discount to its 52-week high of $9.24, offering almost -104.42% off that amount. The share price’s 52-week low was $3.76, which indicates that the current value has risen by an impressive 16.81% since then.

Health Catalyst Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.57. If we narrow it down even further, the data shows that 0 out of 14 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 4 recommended HCAT as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight. Health Catalyst Inc is expected to report earnings per share of 0.0 for the current quarter.

Health Catalyst Inc (NASDAQ:HCAT) trade information

Instantly HCAT has showed a red trend with a performance of -1.74% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.09 on recent trading dayincreased the stock’s daily price by 11.2%. The company’s shares are currently down -36.07% year-to-date, but still down -8.69% over the last five days. On the other hand, Health Catalyst Inc (NASDAQ:HCAT) is -19.72% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to increase their stock price by 35.43% from its current value. Analyst projections state that HCAT is forecast to be at a low of $7 and a high of $7.

Health Catalyst Inc (HCAT) estimates and forecasts

The year-over-year growth rate is expected to be 9.14%, up from the previous year.

Consensus estimates provided by 12 financial analysts predict the company will bring in an average of 79.23M in revenue for the current quarter. 12 analysts expect Health Catalyst Inc to make 82.66M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 74.72M and 75.9M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 6.03%. Forecasts for the next quarter put sales growth at 8.91%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 38.24%. Health Catalyst Inc earnings are expected to increase by 2.58% in 2025, but the outlook is positive 35.51% per year for the next five years.

HCAT Dividends

Health Catalyst Inc’s next quarterly earnings report is expected to be released in April.

VANGUARD GROUP INC, with 7.7263% or 4.53 million shares worth $28.93 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Pax World Small Cap Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.75 shares worth $12.43 million, making up 3.92% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 1.82 shares worth around $8.24 million, which represents about 2.60% of the total shares outstanding.